Literature DB >> 15033343

Deletion of guanine nucleotide binding protein alpha z subunit in mice induces a gene dose dependent tolerance to morphine.

K J Leck1, S E Bartlett, M T Smith, D Megirian, J Holgate, K L Powell, K I Matthaei, I A Hendry.   

Abstract

The mechanism underlying the development of tolerance to morphine is still incompletely understood. Morphine binds to opioid receptors, which in turn activates downstream second messenger cascades through heterotrimeric guanine nucleotide binding proteins (G proteins). In this paper, we show that G(z), a member of the inhibitory G protein family, plays an important role in mediating the analgesic and lethality effects of morphine after tolerance development. We blocked signaling through the G(z) second messenger cascade by genetic ablation of the alpha subunit of the G protein in mice. The Galpha(z) knockout mouse develops significantly increased tolerance to morphine, which depends on Galpha(z) gene dosage. Further experiments demonstrate that the enhanced morphine tolerance is not caused by pharmacokinetic and behavioural learning mechanisms. The results suggest that G(z) signaling pathways are involved in transducing the analgesic and lethality effects of morphine following chronic morphine treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15033343     DOI: 10.1016/j.neuropharm.2003.11.024

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  7 in total

Review 1.  Candidate gene polymorphisms predicting individual sensitivity to opioids.

Authors:  Shinya Kasai; Masakazu Hayashida; Ichiro Sora; Kazutaka Ikeda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-13       Impact factor: 3.000

2.  Deletion of GαZ protein protects against diet-induced glucose intolerance via expansion of β-cell mass.

Authors:  Michelle E Kimple; Jennifer B Moss; Harpreet K Brar; Taylor C Rosa; Nathan A Truchan; Renee L Pasker; Christopher B Newgard; Patrick J Casey
Journal:  J Biol Chem       Date:  2012-03-28       Impact factor: 5.157

3.  Enhanced effect of dopaminergic stimulation on prepulse inhibition in mice deficient in the alpha subunit of G(z).

Authors:  M van den Buuse; S Martin; J Brosda; K J Leck; K I Matthaei; I Hendry
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

4.  Interruption of continuous opioid exposure exacerbates drug-evoked adaptations in the mesolimbic dopamine system.

Authors:  Emilia M Lefevre; Marc T Pisansky; Carlee Toddes; Federico Baruffaldi; Marco Pravetoni; Lin Tian; Thomas J Y Kono; Patrick E Rothwell
Journal:  Neuropsychopharmacology       Date:  2020-02-20       Impact factor: 7.853

Review 5.  Tolerance and withdrawal from prolonged opioid use in critically ill children.

Authors:  Kanwaljeet J S Anand; Douglas F Willson; John Berger; Rick Harrison; Kathleen L Meert; Jerry Zimmerman; Joseph Carcillo; Christopher J L Newth; Parthak Prodhan; J Michael Dean; Carol Nicholson
Journal:  Pediatrics       Date:  2010-04-19       Impact factor: 7.124

6.  HIV-1 Tat-mediated astrocytic amyloidosis involves the HIF-1α/lncRNA BACE1-AS axis.

Authors:  Susmita Sil; Guoku Hu; Ke Liao; Fang Niu; Shannon Callen; Palsamy Periyasamy; Howard S Fox; Shilpa Buch
Journal:  PLoS Biol       Date:  2020-05-26       Impact factor: 8.029

7.  Structure-Based Evolution of G Protein-Biased μ-Opioid Receptor Agonists.

Authors:  Haoqing Wang; Florian Hetzer; Weijiao Huang; Qianhui Qu; Justin Meyerowitz; Jonas Kaindl; Harald Hübner; Georgios Skiniotis; Brian K Kobilka; Peter Gmeiner
Journal:  Angew Chem Int Ed Engl       Date:  2022-04-29       Impact factor: 16.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.